Clinical Trials Directory

Trials / Unknown

UnknownNCT05304325

Adipose Tissue Pre and Post Bariatric Surgery

Evaluation of Adipose Tissue Pre and Post Bariatric Surgery

Status
Unknown
Phase
Study type
Observational
Enrollment
98 (actual)
Sponsor
Institut de Recherches Cliniques de Montreal · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Published data suggest that inflammation and fibrosis of adipose tissue could be factors favoring the development of insulin resistance in obese individuals and that a decrease in the activity of the AMP-activity kinase protein (AMPK) could lead to these dysfunctions. However, very few data are available in humans. There is also growing interest in persistent organic pollutants (POPs) as a cardiometabolic and type 2 diabetes (T2D) risk factor. There is some evidence to suggest that POPs directly contribute to lipid metabolism dysfunction and insulin resistance. Additionally, POPs are stocked in adipose tissue. The accumulation of POPs in adipose tissue therefore limits their bioavailability to other organs, thus reducing their systemic toxicity. It has been observed that a large amplitude weight loss leads to a significant increase in POPs in the blood. The goal of this project is to identify adipose tissue factors/dysfunctions that contribute to insulin resistance and type 2 diabetes associated with obesity in humans and thus raise avenues for screening and treatment of these metabolic complications. More specifically, the objectives are: * To study the relationship between AMPK, fibrosis and inflammation of adipose tissue and their role in the development of insulin resistance and T2D associated with obesity; * To examine the relationship between POPs and the cardiometabolic profile.

Conditions

Interventions

TypeNameDescription
PROCEDUREBariatric surgerySleeve gastrectomy
OTHERBlood samplingBlood samples will be collected to measure glucose, insulin, albumin, uric acid, HbA1c, lipids, hepatic enzymes, TSH, hs-CRP, complete blood cell counts and persistant organic pollutants
OTHERBlood pressureSystolic and diastolic blood pressure will be measured.
OTHERAnthropometric measurementsBody weight, height and waist circumference will be measured.
OTHERBody compositionBody composition will be evaluated by dual-energy X-ray absorptiometry.
OTHERResting metabolic rateResting metabolic rate will be measured by indirect calorimetry.
OTHERFood intakeFood intake, energy intake and food quality will be evaluated using the food frequence questionnaire.
PROCEDUREAdipose tissue biopsyA sample of 3-5g of adipose tissue will be collected under local anesthesia by needle aspiration in the periumbilical region.

Timeline

Start date
2012-04-25
Primary completion
2022-07-31
Completion
2022-09-30
First posted
2022-03-31
Last updated
2022-03-31

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05304325. Inclusion in this directory is not an endorsement.